Market Overview:
The global medical grade chitosan market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for wound care products, healthcare products, and antibacterial products. Additionally, the growing awareness about the benefits of chitosan is also contributing to the growth of this market. Animal origin chitosan held a major share of this market in 2017 and is expected to continue its dominance during the forecast period.
Product Definition:
A medical grade chitosan is a purified form of chitin, which is a polysaccharide made from the shells of crustaceans such as shrimp, crab, and lobster. Chitosan has been used for many years in medical settings due to its ability to bind to bacteria, viruses, and other toxins. When bound to these toxins, chitosan can help remove them from the body. Additionally, because chitosan is able to cross the blood-brain barrier, it has been shown to be effective at reducing inflammation in the brain.
Animal Origin Chitosan:
Animal origin chitosan is a form of chitin, which is extracted from the shells of crabs, lobster and shrimp. It has high demand in pharmaceutical and cosmetic industries due to its anti-microbial properties. The product also finds application in nutraceuticals as it possesses antioxidant characteristics.
The product also helps enhance immune function along with providing relief from joint pain caused by arthritis or gouty arthritis.
Plant Based Chitosan:
Plant based chitosan is a form of chitosan that is extracted from the shells of plant exoskeletons including coconut, soybean, and cashew. It has high demand in medical grade chitosan market on account of its bioavailability as well as low cost compared to animal based products.
Application Insights:
The wound care segment dominated the global medical grade chitosan market in 2017. The antibacterial properties of chitosan have led to its extensive use in various wound care products such as dressings, bandages and plasters. It is also used for the treatment of chronic wounds and burns due to its high healing properties. Increasing cases of chronic diseases across the globe are anticipated to boost demand for advanced wound care products containing natural ingredients, which is likely to propel growth over the forecast period.
The healthcare products segment accounted for a significant share in 2017 owing to rising awareness about maintaining good oral hygiene among patients suffering from diabetes or with a history of cancer or cardiovascular diseases undergoing chelation therapy (the process where metals are removed from their body).
Regional Analysis:
North America was the second-largest regional market in 2017. The region is expected to maintain its position through the forecast period owing to increasing healthcare expenditure and awareness regarding wound care products. Asia Pacific is anticipated to be the fastest-growing regional market from 2018 to 2030 due mainlyto rising demand for chitosan as an antibiotic, wound dressing, and other medical applications in this region.
The global medical grade chitosan market by application (wound care, healthcare products).
Moreover, growing disposable income coupled with a rise in consumer health consciousness will drive growth over the forecast period.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global medical grade chitosan market is expected to benefit from the increasing demand for minimally invasive surgeries. This is because medical grade chitosan helps in reducing surgical trauma and also aids in the faster healing of tissues.
- Rising prevalence of chronic diseases: The global medical grade chitosan market is also expected to benefit from the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. This is because medical grade chitosan helps in inhibiting the growth of these diseases and also aids in their treatment.
- Growing use of biodegradable implants: The global medical grade chitosan market is also expected to benefit from the growing use of biodegradable implants made from natural materials such as collagen and hyaluronic acid. This is because these implants degrade over time without causing any harm to the body tissues unlike traditional metal or plastic implants which can cause inflammation and other side effects post-surgery.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Grade Chitosan Market Research Report
By Type
Animal Origin Chitosan, Plant Based Chitosan
By Application
Wound Care, Healthcare Products, Antibacterial Products, Others
By Companies
Primex, KitoZyme, BIO21, YSK, Vietnam Food, NovaMatrix, KIMICA, Ningbo Zhenhai Haixin Biological, Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech, Jiangsu Shuanglin, Jiangsu Aoxin Biotechnology, Qingdao Yunzhou Biochemistry
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Medical Grade Chitosan Market Report Segments:
The global Medical Grade Chitosan market is segmented on the basis of:
Types
Animal Origin Chitosan, Plant Based Chitosan
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Wound Care, Healthcare Products, Antibacterial Products, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Primex
- KitoZyme
- BIO21
- YSK
- Vietnam Food
- NovaMatrix
- KIMICA
- Ningbo Zhenhai Haixin Biological
- Golden-Shell Pharmaceutical
- Zhejiang Fengrun Biotech
- Jiangsu Shuanglin
- Jiangsu Aoxin Biotechnology
- Qingdao Yunzhou Biochemistry
Highlights of The Medical Grade Chitosan Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Animal Origin Chitosan
- Plant Based Chitosan
- By Application:
- Wound Care
- Healthcare Products
- Antibacterial Products
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Grade Chitosan Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical grade chitosan is a type of chitin that has been processed to remove any contaminants. It is often used in medical treatments because it is a strong adhesive and can be absorbed by the body relatively easily.
Some of the major companies in the medical grade chitosan market are Primex, KitoZyme, BIO21, YSK, Vietnam Food, NovaMatrix, KIMICA, Ningbo Zhenhai Haixin Biological, Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech, Jiangsu Shuanglin, Jiangsu Aoxin Biotechnology, Qingdao Yunzhou Biochemistry.
The medical grade chitosan market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Grade Chitosan Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Grade Chitosan Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Grade Chitosan Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Grade Chitosan Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Grade Chitosan Market Size & Forecast, 2020-2028
4.5.1 Medical Grade Chitosan Market Size and Y-o-Y Growth
4.5.2 Medical Grade Chitosan Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Animal Origin Chitosan
5.2.2 Plant Based Chitosan
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Wound Care
6.2.2 Healthcare Products
6.2.3 Antibacterial Products
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Grade Chitosan Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Grade Chitosan Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Animal Origin Chitosan
9.6.2 Plant Based Chitosan
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Wound Care
9.10.2 Healthcare Products
9.10.3 Antibacterial Products
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Animal Origin Chitosan
10.6.2 Plant Based Chitosan
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Wound Care
10.10.2 Healthcare Products
10.10.3 Antibacterial Products
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Animal Origin Chitosan
11.6.2 Plant Based Chitosan
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Wound Care
11.10.2 Healthcare Products
11.10.3 Antibacterial Products
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Animal Origin Chitosan
12.6.2 Plant Based Chitosan
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Wound Care
12.10.2 Healthcare Products
12.10.3 Antibacterial Products
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Animal Origin Chitosan
13.6.2 Plant Based Chitosan
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Wound Care
13.10.2 Healthcare Products
13.10.3 Antibacterial Products
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Grade Chitosan Market: Competitive Dashboard
14.2 Global Medical Grade Chitosan Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Primex
14.3.2 KitoZyme
14.3.3 BIO21
14.3.4 YSK
14.3.5 Vietnam Food
14.3.6 NovaMatrix
14.3.7 KIMICA
14.3.8 Ningbo Zhenhai Haixin Biological
14.3.9 Golden-Shell Pharmaceutical
14.3.10 Zhejiang Fengrun Biotech
14.3.11 Jiangsu Shuanglin
14.3.12 Jiangsu Aoxin Biotechnology
14.3.13 Qingdao Yunzhou Biochemistry
